What is “Advair HFA” 115/21?
“Advair HFA” refers to a prescription inhaler that combines fluticasone propionate (an inhaled corticosteroid) and albuterol sulfate (a short-acting bronchodilator). The label number 115/21 typically indicates the fluticasone dose per actuation (115 mcg) and the albuterol dose per actuation (21 mcg).
What is it used for?
Advair HFA is used to help control symptoms of asthma in people who need both:
- a controller inhaled steroid, and
- a fast-acting rescue bronchodilator for symptom relief.
How is it different from Advair Diskus (powder)?
Advair HFA is a pressurized metered-dose inhaler (MDI). Advair Diskus is a dry-powder inhaler (DPI). The devices deliver the medicine differently, so patients should follow the specific inhaler technique for the one they have.
How should patients take Advair HFA 115/21?
Follow the prescriber’s instructions for dosing and inhaler technique. The main safety point is that albuterol-containing inhalers like this should not replace emergency care if breathing worsens or severe symptoms occur.
Side effects people ask about
Common side effects can include:
- throat irritation or hoarseness (from inhaled steroid),
- mouth/throat fungal infection (thrush), and
- tremor or fast heartbeat (from the bronchodilator).
Rinsing the mouth after inhalation is a common practical step to reduce throat side effects (especially thrush risk).
What if symptoms aren’t controlled?
If asthma symptoms persist or increase, patients typically need a reassessment of:
- correct inhaler technique,
- adherence (timing and regular use),
- whether the dose is appropriate, or
- whether therapy should be adjusted.
Want the exact product details?
“Advair HFA 115/21” can appear in different packaging/labeling formats depending on the country and the specific version. If you tell me what you need—pricing, availability, side effects, dosing schedule, or whether it’s been discontinued—I can narrow it down.